Anti-Snake Venom (ASV) in Kenya

Overview

Anti-snake venom (ASV) is a life-saving biologic used to treat envenomation from venomous snakebites. Kenya uses polyvalent ASV effective against common species like puff adders, cobras, and mambas. It neutralizes toxins, preventing paralysis, hemorrhage, and death. ASV is NOT over-the-counter – administered only in hospitals/clinics under medical supervision.

Composition

• Type: Polyvalent ASV (covers multiple snake species).
• Formulation: Lyophilized powder for reconstitution (vials) or liquid (rare).
• Active Ingredients: Purified immunoglobulins (IgG) from horses/sheep immunized with snake venom.
• Kenyan Brands:
  • SNAKE VENOM ANTISERUM (Polyvalent) by KEMRI (Kenya Medical Research Institute).
  • VINS Polyvalent ASV (imported, used in private hospitals).
• Neutralization Capacity:
  • Low Dose: 1 vial neutralizes venom from one snakebite (varies by species).
  • High Dose: 5–10 vials for severe envenomation.

Side Effects

Common

• Early Reactions (Anaphylaxis):
  • Itching, rash, fever, chills (within 10–180 minutes).
  • Hypotension, bronchospasm (rare; requires adrenaline).
• Late Reactions (Serum Sickness):
  • Fever, joint pain, swollen lymph nodes (5–24 days post-ASV).

Serious Risks

• Anaphylactic Shock: Airway obstruction, cardiac arrest (requires emergency epinephrine).
• Pyrogen Reactions: High fever, rigors (due to contaminants).
• Renal Failure: From venom or ASV toxicity (monitor urine output).

How to Use

• Administration:
  • Route: Intravenous (IV) infusion only (never IM/SC).
  • Reconstitution: Dilute lyophilized ASV in 500mL saline/dextrose.
  • Dosage:

    Envenomation Severity	ASV Dose	Infusion Duration
    Mild	5–10 vials	1–2 hours
    Severe	15–20 vials	4–6 hours
    Children	Weight-based (e.g., 10 vials/20kg)	As above

  • Pre-Medication:
    • Adrenaline, antihistamines, and corticosteroids to prevent anaphylaxis.
• Critical Protocols:
  • Skin Test: Optional (not predictive; proceed cautiously even if positive).
  • Slow Infusion: Start at 1mL/min; increase if no reaction.
  • Resuscitation Ready: Have adrenaline, oxygen, and IV fluids at bedside.

Frequently Asked Questions

1. Is ASV available over-the-counter?
   No – restricted to hospitals/clinics due to anaphylaxis risk.

2. Where can I access ASV in Kenya?

   • Public Hospitals: County referral facilities (e.g., Machakos Level 5, Kakamega Referral).
   • Private Hospitals: Nairobi, Mombasa, and Eldoret (e.g., Aga Khan, Nairobi Hospital).
   • NGOs: MSF (Doctors Without Borders) in high-risk areas (e.g., Turkana, Baringo).

3. Does NHIF cover ASV?
   Yes – fully covered in public hospitals; partial coverage in private facilities.

4. What if ASV is unavailable?

   • Transfer immediately to stocked facilities.
   • Supportive Care: IV fluids, wound care, airway management (buy time).

5. Can traditional healers treat snakebites?
   No – ASV is the only proven antidote. Delays increase mortality.

6. How much does ASV cost?

   • Public Hospitals: Free (government-funded).
   • Private Hospitals: KES 15,000–40,000 per vial (severe cases cost KES 600,000+).

7. Should I apply a tourniquet?
   No – worsens tissue damage. Use pressure immobilization for neurotoxic bites (e.g., mambas).

Conclusion

Anti-snake venom is the cornerstone of snakebite management in Kenya, but access remains a challenge due to stockouts in rural areas and high costs in private facilities. Kenya’s polyvalent ASV is effective against major venomous species but requires urgent administration within the “golden hour” (first 1–2 hours). Public hospitals provide free ASV, but referral delays are common. Community education on first aid (immobilization, hospital transfer) and avoiding harmful practices (tourniquets, incisions) is critical. For high-risk regions (e.g., arid/semi-arid zones), strengthening cold-chain storage and training healthcare workers in ASV administration can save lives. Always seek immediate medical care – ASV is the only proven antidote for snake envenomation.